Old Web
English
Sign In
Acemap
>
authorDetail
>
R Fuhr
R Fuhr
PAREXEL
Internal medicine
Medicine
Confidence interval
Physical therapy
Adverse effect
5
Papers
51
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
P449 Selective depletion of LAG3+ cells in T-cell-driven inflammation: a randomised, double-blind, placebo-controlled, FTIH phase I/Ib clinical trial
2019
Journal of Crohns & Colitis
J Ellis
D Marks
C. Barrett
T Hopkins
A Richards
R Fuhr
M. Albayaty
M. Coenen
L Liefaard
K Leavens
K Nevin
S Tang
S Hughes
N Srinivasan
Kenneth A. Edwards
R Anselm
Tim Schmidt
J Stone
Caroline Os Savage
N Wisniacki
R Tarzi
Show All
Source
Cite
Save
Citations (2)
A randomized phase I comparative pharmacokinetic study comparing SB5 with reference adalimumab in healthy volunteers
2017
Journal of Clinical Pharmacy and Therapeutics
Donghoon Shin
Y. Lee
H.S. Kim
T. Körnicke
R Fuhr
Show All
Source
Cite
Save
Citations (33)
FRI0110 A Phase I Pharmacokinetic Study Comparing SB5, An Adalimumab Biosimilar, And Adalimumab Reference Product (Humira®) in Healthy Subjects
2015
Annals of the Rheumatic Diseases
Donghoon Shin
Youngdoe Kim
H.S. Kim
R Fuhr
T. Körnicke
Show All
Source
Cite
Save
Citations (7)
SAT0176 A Phase I Pharmacokinetic Study Comparing SB4, An Etanercept Biosimilar, and Etanercept Reference Product (Enbrel®) in Healthy Male Subjects
2015
Annals of the Rheumatic Diseases
Younju Lee
Donghoon Shin
Youngdoe Kim
Jung Won Kang
R Fuhr
A. Gauliard
Show All
Source
Cite
Save
Citations (6)
SAT0144 A Phase I Pharmacokinetic Study Comparing SB2, An Infliximab Biosimilar, And Infliximab Reference Product (Remicade®) in Healthy Subjects
2015
Annals of the Rheumatic Diseases
Donghoon Shin
Youngdoe Kim
Y.S. Kim
R Fuhr
T. Körnicke
Show All
Source
Cite
Save
Citations (3)
1